LISA WALLACE: Open Payments
NPI 1235637182 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,443 in 76 payments from 26 companies in 2025. Trend: 2023 $1,534 · 2024 $1,679 · 2025 $1,443
Food & beverage: $1,443
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $226 |
| PFIZER INC. | 13 | $181 |
| Abbott Laboratories | 2 | $141 |
| GlaxoSmithKline, LLC. | 7 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $88 |
| Corcept Therapeutics | 3 | $67 |
| Esperion Therapeutics, Inc. | 3 | $60 |
| Dexcom, Inc. | 3 | $59 |
| Novo Nordisk Inc | 3 | $52 |
| Merck Sharp & Dohme LLC | 3 | $51 |
Products named: AIRSUPRA, CARDIOMEMS, FARXIGA, JARDIANCE, NURTEC ODT, Korlym, PREVNAR 20, NEXLETOL.
Industry payments across SC — which companies pay providers there.
